ACURX PHARMACEUTICALS INC

ACXP is the ticker symbol for Acurx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company. It is listed on the Nasdaq Capital Market. The stock represents equity ownership in the company, which focuses on developing novel antibiotics for bacterial infections. As a clinical-stage firm, its value is closely tied to the progress of its drug candidates, making it a speculative holding. The latest details on ACXP are available on its stock detail page.

The current price of ACXP stock fluctuates throughout the trading day based on supply and demand. For the most up-to-date price, please refer to the live quote displayed at the top of this page. The page also provides other real-time metrics such as the day's range, volume, and market capitalization, ensuring you have the latest information without relying on potentially outdated figures.

Volatility for ACXP can be significant due to its status as a small-cap, clinical-stage biopharmaceutical company. Share prices often react sharply to news about clinical trials, regulatory developments, and financing activities. Investors should be aware that such stocks can experience large price swings over short periods. For historical volatility measures, consult the chart and statistics provided on the ACXP stock detail page.

Evaluating ACXP requires a different approach than established profitable companies. Traditional metrics like the P/E ratio may not be meaningful because clinical-stage biotechs often have no product revenue or earnings. Instead, investors may consider factors such as cash position, pipeline potential, and analyst estimates of future sales. The valuation section on the ACXP detail page may offer relevant ratios; use them alongside qualitative research.

ACXP stock may be traded in pre-market and after-hours sessions, though liquidity is typically lower than during regular market hours. These extended-hours trades occur on electronic communication networks (ECNs) and may have wider spreads. Not all brokers offer extended-hours trading, and prices can be more volatile. Check with your brokerage for specific availability and any associated fees or restrictions.

ACXP does not pay dividends, as is common for clinical-stage biotechnology companies that reinvest capital into research and development. Therefore, there is no dividend yield or dividend history to evaluate. Investors seeking income may look elsewhere, while those focused on growth potential might consider ACXP for its pipeline prospects. Always verify the latest dividend policy on the ACXP stock detail page or in company filings.